title: In reply.
authors.affiliation: Department of Emergency Medicine, Section of Medical Toxicology, University of Southern California, Los Angeles, CA.
authors.forename: Michael
authors.initials: M
authors.lastname: Levine
authors.affiliation: Department of Medical Toxicology, Banner Good Samaritan Medical Center, Center for Toxicology and Pharmacology Education and Research, University of Arizona College of Medicine-Phoenix, Phoenix, AZ.
authors.forename: Steven
authors.initials: S
authors.lastname: Curry
authors.affiliation: Department of Medical Toxicology, Banner Good Samaritan Medical Center, Center for Toxicology and Pharmacology Education and Research, University of Arizona College of Medicine-Phoenix, Phoenix, AZ.
authors.forename: Anne-Michelle
authors.initials: AM
authors.lastname: Ruha
authors.affiliation: Banner Research Institute, Phoenix, AZ.
authors.forename: Angella
authors.initials: A
authors.lastname: Padilla-Jones
mesh_terms: D002121:Calcium Channel Blockers / Q000506:poisoning*; D003422:Critical Care / Q000379:methods*; D004110:Diltiazem / Q000506:poisoning*; D062787:Drug Overdose / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014700:Verapamil / Q000506:poisoning*
chemical_list: D002121:Calcium Channel Blockers; D014662:Vasoconstrictor Agents; D014700:Verapamil; D004110:Diltiazem